BioSpace News Archive

Satellos Bioscience Inc. (TSXV: MSCL) (“Satellos” or the “Corporation”), a regenerative medicine company aimed at developing therapeutics that change the way degenerative muscle diseases are treated, filed its financial and operating results on 29 August 2022 for the quarter ended June 30, 2022.

HighTide Therapeutics, Inc. (“HighTide”), announced that enrollment was completed ahead of schedule in a Phase 2 study evaluating HTD1801 in patients with type 2 diabetes mellitus (T2DM) in China.

(“Nextleaf” or the “Company”), a federally regulated manufacturer and distributor of cannabis extracts including vapes and oils, announced today its Q3 financial and operational results for the quarter ended June 30, 2022 (“Q3 2022").

(“Hemostemix” or the “Company”) is pleased to announce the results of its Phase II Clinical Trial and the results of a new retrospective study of patients that underwent a trans-catheter, intramyocardial injection of angiogenic cell precursors (ACP-01) as a treatment for heart failure (ischemic and non-ischemic dilated cardiomyopathy).

Britannia Life Sciences Inc. (CSE: BLAB) (“Britannia” or the “Company”) is pleased to provide its unaudited financial results for the three months ended June 30, 2022.

A new National Institutes of Health -funded study found that pregnant people are exposed to a variety of dangerous chemicals commonly found in household products.

Target ALS and the Alzheimer’s Drug Discovery Foundation (ADDF) announced today the first four award recipients in a new initiative to identify and develop biomarkers for neurodegenerative diseases, including Alzheimer’s disease, Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Degeneration (FTD).

Oneview Healthcare announced the launch of a system-wide expansion of Oneview’s Care Experience Platform (CXP) with BJC HealthCare in St. Louis.

The latest market analysis report published by Reports and Data, titled ‘Global Lymphoma Market – Forecast to 2030,’ thoroughly examines the Lymphoma industry to provide essential data & information for the targeted readers.

The latest market analysis report published by Reports and Data, titled ‘Global Localized Scleroderma Market – Forecast to 2030,’ thoroughly examines the Localized Scleroderma industry to provide essential data & information for the targeted readers.